MEDIFAST (MED)
(Delayed Data from NYSE)
$35.51 USD
+1.80 (5.34%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $29.03 -6.48 (-18.25%) 7:58 PM ET
5-Strong Sell of 5 5
A Value B Growth F Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MED 35.51 +1.80(5.34%)
Will MED be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for MED based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MED
Medifast's (MED) Transformation on Track Amid Macro Headwinds
MEDIFAST (MED) Down 11.5% Since Last Earnings Report: Can It Rebound?
MED: What are Zacks experts saying now?
Zacks Private Portfolio Services
Medifast (MED) Soars 5.9%: Is Further Upside Left in the Stock?
Innovations Aid Medifast (MED), Lower Customer Attraction Ails
Medifast (MED) Q4 Earnings Beat Estimates, Revenues Dip Y/Y
Other News for MED
Medifast: Q1 Earnings Snapshot
Medifast Announces First Quarter 2024 Financial Results
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
MED Stock Earnings: Medifast Misses EPS, Beats Revenue for Q1 2024
Fly Intel: After-Hours Movers